Toll Free: 1-888-928-9744
Published: Aug, 2019 | Pages:
108 | Publisher: MAResearch
Industry: Medical Devices | Report Format: Electronic (PDF)
The global Hemophilia Gene Therapy market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Hemophilia Gene Therapy from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Hemophilia Gene Therapy market. Leading players of Hemophilia Gene Therapy including: Spark Therapeutics Ultragenyx Shire PLC Sangamo Therapeutics Bioverativ BioMarin uniQure Freeline Therapeutics Market split by Type, can be divided into: Hemophilia A Hemophilia B Market split by Application, can be divided into: Hemophilia A Gene Therapy Hemophilia B Gene Therapy Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents Chapter 1 Hemophilia Gene Therapy Market Overview 1.1 Hemophilia Gene Therapy Definition 1.2 Global Hemophilia Gene Therapy Market Size Status and Outlook (2013-2028) 1.3 Global Hemophilia Gene Therapy Market Size Comparison by Region (2013-2028) 1.4 Global Hemophilia Gene Therapy Market Size Comparison by Type (2013-2028) 1.5 Global Hemophilia Gene Therapy Market Size Comparison by Application (2013-2028) 1.6 Global Hemophilia Gene Therapy Market Size Comparison by Sales Channel (2013-2028) 1.7 Hemophilia Gene Therapy Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Hemophilia Gene Therapy Market Segment Analysis by Player 2.1 Global Hemophilia Gene Therapy Sales and Market Share by Player (2016-2018) 2.2 Global Hemophilia Gene Therapy Revenue and Market Share by Player (2016-2018) 2.3 Global Hemophilia Gene Therapy Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Hemophilia Gene Therapy Market Segment Analysis by Type 3.1 Global Hemophilia Gene Therapy Market by Type 3.1.1 Hemophilia A 3.1.2 Hemophilia B 3.2 Global Hemophilia Gene Therapy Sales and Market Share by Type (2013-2018) 3.3 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2013-2018) 3.4 Global Hemophilia Gene Therapy Average Price by Type (2013-2018) 3.5 Leading Players of Hemophilia Gene Therapy by Type in 2018 3.6 Conclusion of Segment by Type Chapter 4 Hemophilia Gene Therapy Market Segment Analysis by Application 4.1 Global Hemophilia Gene Therapy Market by Application 4.1.1 Hemophilia A Gene Therapy 4.1.2 Hemophilia B Gene Therapy 4.2 Global Hemophilia Gene Therapy Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Hemophilia Gene Therapy by Application in 2018 4.4 Conclusion of Segment by Application Chapter 5 Hemophilia Gene Therapy Market Segment Analysis by Sales Channel 5.1 Global Hemophilia Gene Therapy Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Hemophilia Gene Therapy Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Hemophilia Gene Therapy by Sales Channel in 2018 5.4 Conclusion of Segment by Sales Channel Chapter 6 Hemophilia Gene Therapy Market Segment Analysis by Region 6.1 Global Hemophilia Gene Therapy Market Size and CAGR by Region (2013-2028) 6.2 Global Hemophilia Gene Therapy Sales and Market Share by Region (2013-2018) 6.3 Global Hemophilia Gene Therapy Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Hemophilia Gene Therapy Market Share by Type 6.4.3 North America Hemophilia Gene Therapy Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Hemophilia Gene Therapy Market Share by Type 6.5.3 Europe Hemophilia Gene Therapy Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Hemophilia Gene Therapy Market Share by Type 6.6.3 Asia-Pacific Hemophilia Gene Therapy Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Hemophilia Gene Therapy Market Share by Type 6.7.3 South America Hemophilia Gene Therapy Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Hemophilia Gene Therapy Market Share by Type 6.8.3 Middle East & Africa Hemophilia Gene Therapy Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Hemophilia Gene Therapy Players 7.1 Spark Therapeutics 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Ultragenyx 7.3 Shire PLC 7.4 Sangamo Therapeutics 7.5 Bioverativ 7.6 BioMarin 7.7 uniQure 7.8 Freeline Therapeutics Chapter 8 Upstream and Downstream Analysis of Hemophilia Gene Therapy 8.1 Industrial Chain of Hemophilia Gene Therapy 8.2 Upstream of Hemophilia Gene Therapy 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Hemophilia Gene Therapy 8.3.1 Leading Distributors/Dealers of Hemophilia Gene Therapy 8.3.2 Leading Consumers of Hemophilia Gene Therapy Chapter 9 Development Trend of Hemophilia Gene Therapy (2019-2028) 9.1 Global Hemophilia Gene Therapy Market Size (Sales and Revenue) Forecast (2019-2028) 9.2 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2019-2028) 9.3 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2019-2028) 9.4 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2019-2028) 9.5 Global Hemophilia Gene Therapy Market Size Forecast by Sales Channel (2019-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
List of Tables and Figures Figure Hemophilia Gene Therapy Example Figure Global Hemophilia Gene Therapy Revenue (Million $) Status and Outlook (2013-2028) Figure Global Hemophilia Gene Therapy Revenue (Million $) Comparison by Region (2013-2028) Figure Global Hemophilia Gene Therapy Sales Comparison by Type (2013-2028) Figure Global Hemophilia Gene Therapy Sales Comparison by Application (2013-2028) Figure Global Hemophilia Gene Therapy Sales Comparison by Sales Channel (2013-2028) Table Global Hemophilia Gene Therapy Sales by Player (2016-2018) Table Global Hemophilia Gene Therapy Sales Market Share by Player (2016-2018) Figure Global Hemophilia Gene Therapy Sales Market Share by Player in 2018 Table Global Hemophilia Gene Therapy Revenue (Million $) by Player (2016-2018) Table Global Hemophilia Gene Therapy Revenue Market Share by Player (2016-2018) Figure Global Hemophilia Gene Therapy Revenue Market Share by Player in 2018 Table Global Hemophilia Gene Therapy Average Price by Player (2016-2018) Figure Global Hemophilia Gene Therapy Average Price by Player in 2018 Figure Global Hemophilia Gene Therapy Players Competition Situation - Top 5 Players' Revenue Market Share in 2016 Figure Global Hemophilia Gene Therapy Players Competition Trends - Top 5 Players' Revenue Market Share in 2018 Figure Example of Hemophilia A Figure Global Hemophilia A Sales and Growth Rate (2013-2018) Figure Example of Hemophilia B Figure Global Hemophilia B Sales and Growth Rate (2013-2018) Table Global Hemophilia Gene Therapy Sales by Type (2013-2018) Table Global Hemophilia Gene Therapy Sales Market Share by Type (2013-2018) Figure Global Hemophilia Gene Therapy Sales Market Share by Type in 2018 Table Global Hemophilia Gene Therapy Revenue (Million $) by Type (2013-2018) Table Global Hemophilia Gene Therapy Revenue Market Share by Type (2013-2018) Figure Global Hemophilia Gene Therapy Revenue Market Share by Type in 2018 Table Global Hemophilia Gene Therapy Average Price by Type (2013-2018) Figure Global Hemophilia Gene Therapy Average Price by Type in 2018 Table Leading Players of Hemophilia Gene Therapy by Type in 2018 Figure Example of Hemophilia A Gene Therapy Figure Global Hemophilia Gene Therapy for Hemophilia A Gene Therapy Sales and Growth Rate (2013-2018) Figure Example of Hemophilia B Gene Therapy Figure Global Hemophilia Gene Therapy for Hemophilia B Gene Therapy Sales and Growth Rate (2013-2018) Table Global Hemophilia Gene Therapy Sales by Application (2013-2018) Table Global Hemophilia Gene Therapy Sales Market Share by Application (2013-2018) Figure Global Hemophilia Gene Therapy Sales Market Share by Application in 2018 Table Leading Consumers of Hemophilia Gene Therapy by Application in 2018 Figure Example of Direct Channel Figure Global Hemophilia Gene Therapy for Direct Channel Sales and Growth Rate (2013-2018) Figure Example of Distribution Channel Figure Global Hemophilia Gene Therapy for Distribution Channel Sales and Growth Rate (2013-2018) Table Global Hemophilia Gene Therapy Sales by Sales Channel (2013-2018) Table Global Hemophilia Gene Therapy Sales Market Share by Sales Channel (2013-2018) Figure Global Hemophilia Gene Therapy Sales Market Share by Sales Channel in 2018 Table Leading Distributors/Dealers of Hemophilia Gene Therapy by Sales Channel in 2018 Table Global Hemophilia Gene Therapy Market Size and CAGR by Region (2013-2028) Table Global Hemophilia Gene Therapy Sales by Region (2013-2018) Table Global Hemophilia Gene Therapy Sales Market Share by Region (2013-2018) Figure Global Hemophilia Gene Therapy Sales Market Share by Region in 2018 Table Global Hemophilia Gene Therapy Revenue (Million $) by Region (2013-2018) Table Global Hemophilia Gene Therapy Revenue Market Share by Region (2013-2018) Figure Global Hemophilia Gene Therapy Revenue Market Share by Region in 2018 Table North America Hemophilia Gene Therapy Sales by Country (2013-2018) Figure North America Hemophilia Gene Therapy Sales Market Share by Country (2013-2018) Table North America Hemophilia Gene Therapy Revenue by Country (2013-2018) Figure North America Hemophilia Gene Therapy Revenue Market Share by Country (2013-2018) Figure North America Hemophilia Gene Therapy Sales Market Share by Type in 2018 Figure North America Hemophilia Gene Therapy Sales Market Share by Application in 2018 Figure United States Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure United States Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Canada Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Canada Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Mexico Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Mexico Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Table Europe Hemophilia Gene Therapy Sales by Country (2013-2018) Figure Europe Hemophilia Gene Therapy Sales Market Share by Country (2013-2018) Table Europe Hemophilia Gene Therapy Revenue by Country (2013-2018) Figure Europe Hemophilia Gene Therapy Revenue Market Share by Country (2013-2018) Figure Europe Hemophilia Gene Therapy Sales Market Share by Type in 2018 Figure Europe Hemophilia Gene Therapy Sales Market Share by Application in 2018 Figure Germany Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Germany Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure UK Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure UK Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure France Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure France Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Italy Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Italy Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Russia Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Russia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Spain Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Spain Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Table Asia-Pacific Hemophilia Gene Therapy Sales by Country (2013-2018) Figure Asia-Pacific Hemophilia Gene Therapy Sales Market Share by Country (2013-2018) Table Asia-Pacific Hemophilia Gene Therapy Revenue by Country (2013-2018) Figure Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Country (2013-2018) Figure Asia-Pacific Hemophilia Gene Therapy Sales Market Share by Type in 2018 Figure Asia-Pacific Hemophilia Gene Therapy Sales Market Share by Application in 2018 Figure China Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure China Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Japan Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Japan Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Korea Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Korea Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure India Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure India Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Southeast Asia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Australia Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Australia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Table South America Hemophilia Gene Therapy Sales by Country (2013-2018) Figure South America Hemophilia Gene Therapy Sales Market Share by Country (2013-2018) Table South America Hemophilia Gene Therapy Revenue by Country (2013-2018) Figure South America Hemophilia Gene Therapy Revenue Market Share by Country (2013-2018) Figure South America Hemophilia Gene Therapy Sales Market Share by Type in 2018 Figure South America Hemophilia Gene Therapy Sales Market Share by Application in 2018 Figure Brazil Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Brazil Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Argentina Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Argentina Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Colombia Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Colombia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Chile Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Chile Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Table Middle East & Africa Hemophilia Gene Therapy Sales by Country (2013-2018) Figure Middle East & Africa Hemophilia Gene Therapy Sales Market Share by Country (2013-2018) Table Middle East & Africa Hemophilia Gene Therapy Revenue by Country (2013-2018) Figure Middle East & Africa Hemophilia Gene Therapy Revenue Market Share by Country (2013-2018) Figure Middle East & Africa Hemophilia Gene Therapy Sales Market Share by Type in 2018 Figure Middle East & Africa Hemophilia Gene Therapy Sales Market Share by Application in 2018 Figure Egypt Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Egypt Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Saudi Arabia Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Saudi Arabia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure South Africa Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure South Africa Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Figure Nigeria Hemophilia Gene Therapy Sales and Growth Rate (2013-2018) Figure Nigeria Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2013-2018) Table Company Snapshot of Spark Therapeutics Table Hemophilia Gene Therapy Introduction of Spark Therapeutics Table Hemophilia Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share of Spark Therapeutics (2016-2018) Table Industrial Chain of Hemophilia Gene Therapy Table Manufacturing Cost Structure of Hemophilia Gene Therapy Table General Manufacturing Process of Hemophilia Gene Therapy Table Leading Distributors/Dealers of Hemophilia Gene Therapy Table Leading Consumers of Hemophilia Gene Therapy Figure Global Hemophilia Gene Therapy Sales and Growth Rate Forecast (2019-2028) Figure Global Hemophilia Gene Therapy Revenue and Growth Rate Forecast (2019-2028) Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2019-2028) Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2019-2028) Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2019-2028) Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Sales Channel (2019-2028)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.